CNS Response at the 2010 OneMedForum
George Carpenter, CEO of CNS Response, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
George Carpenter, CEO of CNS Response, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
An interview with Rick Hughes, President of HealthLink Europe, at the 2010 OneMedForum conference.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
Sunnyville, Calif.-based Amarantus Therapeutics is developing therapies to reverse the process of apoptosis.
Laura Strong, President and COO of Quintessence Biosciences, discusses her company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Alexza Pharmaceuticals of Mountain View, Calif., is focused on the development of inhalation drugs for the treatment of central nervous system disorders.
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
Lawrence A. Siebert, President and CEO of Chembio Diagnostics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Micrus Endovascular is the only publicly traded company focused on strokes.
Dr. Joseph Kim, CEO and President of Inovio Biomedical, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Copyright © 2025 | WordPress Theme by MH Themes